Finally, in a large meta-analysis of 14,395 patients with advanced NSCLC receiving ICI, the combination of PD-L1 and TMB was associated with increased power to predict OS, which was further improved with incorporation of CD8+ TILs [97]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.